• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1例新冠病毒疫苗接种后抗中性粒细胞胞浆抗体（ANCA）相关血管炎病例

A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination.

作者信息

Al-Yafeai Zaki, Horn Benjamin Joesph M, Terraccaine William, Jose Alvin, Krishnan Prathik

机构信息

Internal Medicine, LSU (Louisiana State University) Health Shreveport, Shreveport, USA.

Anaesthesia, LSU (Louisiana State University) Health Shreveport, Shreveport, USA.

出版信息

Cureus. 2022 Mar 14;14(3):e23162. doi: 10.7759/cureus.23162. eCollection 2022 Mar.

DOI:10.7759/cureus.23162
PMID:35444915
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9010006/
Abstract

In this report, we examine the case of a patient who developed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. This is a case of a 62-year-old female who received the first dose of COVID-19 vaccine in July 2021 before presenting a few weeks later with migrating polyarthralgia and hemoptysis. Autoimmune workup was positive for ANCA against proteinase 3 (PR3).

摘要

在本报告中，我们研究了一名患者的病例，该患者在接种辉瑞-生物科技公司的2019冠状病毒病（COVID-19）疫苗后发生了抗中性粒细胞胞浆抗体（ANCA）相关血管炎。这是一名62岁女性的病例，她于2021年7月接种了第一剂COVID-19疫苗，几周后出现游走性多关节痛和咯血。自身免疫检查显示抗蛋白酶3（PR3）的ANCA呈阳性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/eff0503c6e66/cureus-0014-00000023162-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/f01c147c5603/cureus-0014-00000023162-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/28566fc0c05d/cureus-0014-00000023162-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/eff0503c6e66/cureus-0014-00000023162-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/f01c147c5603/cureus-0014-00000023162-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/28566fc0c05d/cureus-0014-00000023162-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bcb/9010006/eff0503c6e66/cureus-0014-00000023162-i03.jpg

相似文献

1
A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination.1例新冠病毒疫苗接种后抗中性粒细胞胞浆抗体（ANCA）相关血管炎病例
Cureus. 2022 Mar 14;14(3):e23162. doi: 10.7759/cureus.23162. eCollection 2022 Mar.
2
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.髓过氧化物酶-抗中性粒细胞胞质抗体（ANCA）阳性和 ANCA 阴性的肉芽肿性多血管炎（韦格纳）患者：不同的患者亚群。
Arthritis Rheumatol. 2016 Dec;68(12):2945-2952. doi: 10.1002/art.39812.
3
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.髓过氧化物酶-抗中性粒细胞胞质抗体（ANCA）阳性肉芽肿性多血管炎（韦格纳氏）是一种临床独特的 ANCA 相关血管炎亚型：德国血管炎转诊中心 315 例患者的回顾性分析。
Arthritis Rheumatol. 2016 Dec;68(12):2953-2963. doi: 10.1002/art.39786.
4
Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.抗中性粒细胞胞浆抗体与蛋白酶3前体形式的反应及韦格纳肉芽肿和显微镜下多血管炎患者的疾病活动度
Arthritis Rheum. 2001 Feb;44(2):463-8. doi: 10.1002/1529-0131(200102)44:2<463::AID-ANR65>3.0.CO;2-9.
5
A Diagnostic Dilemma of a Case of Granulomatosis With Polyangiitis (GPA) Presenting With Thrombotic Vasculopathy.一例以血栓性血管病为表现的肉芽肿性多血管炎（GPA）病例的诊断困境
Cureus. 2023 Jan 31;15(1):e34479. doi: 10.7759/cureus.34479. eCollection 2023 Jan.
6
Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.抗中性粒细胞胞浆抗体（ANCA）相关血管炎中的自身抗体和靶抗原
Rheumatol Int. 1996;16(3):109-14. doi: 10.1007/BF01409982.
7
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.针对韦格纳肉芽肿和显微镜下多血管炎中抗蛋白酶3和髓过氧化物酶的抗中性粒细胞胞浆抗体的商业免疫测定的批判性评估。
Rheumatology (Oxford). 2002 Nov;41(11):1313-7. doi: 10.1093/rheumatology/41.11.1313.
8
Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.交替性抗中性粒细胞胞浆抗体特异性：韦格纳肉芽肿患者的药物性血管炎
Arthritis Rheum. 1999 Feb;42(2):384-8. doi: 10.1002/1529-0131(199902)42:2<384::AID-ANR22>3.0.CO;2-X.
9
Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients.抗蛋白酶 3 抗中性粒细胞胞质抗体（ANCA）是否是肉芽肿性多血管炎（韦格纳氏）复发的有用标志物？对 126 例患者进行回顾性研究的结果。
Autoimmun Rev. 2014 Mar;13(3):313-8. doi: 10.1016/j.autrev.2013.11.003. Epub 2013 Nov 10.
10
Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).季节对抗中性粒细胞胞质抗体相关性血管炎发展的影响：日本多机构回顾性队列研究（J-CANVAS）。
J Rheumatol. 2023 Sep;50(9):1152-1158. doi: 10.3899/jrheum.2023-0040. Epub 2023 Jun 1.

引用本文的文献

1
ANCA-related vasculitis incidence and features before and during the COVID-19 pandemic in Los Angeles, Biobio Province, Chile: an observational retrospective analysis.智利比奥比奥省洛杉矶市在2019冠状病毒病大流行之前及期间抗中性粒细胞胞浆抗体相关性血管炎的发病率和特征：一项观察性回顾分析。
Front Nephrol. 2025 Jun 16;5:1599316. doi: 10.3389/fneph.2025.1599316. eCollection 2025.
2
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review.确定新冠相关肾小球肾炎的机制性病因：一项系统综述
Front Med (Lausanne). 2025 Jun 9;12:1568943. doi: 10.3389/fmed.2025.1568943. eCollection 2025.
3
COVID-19 vaccine-associated vasculitis: A systematic review.

本文引用的文献

1
De-novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Following the mRNA-1273 (Moderna) Vaccine for COVID-19.接种新型冠状病毒肺炎mRNA-1273（Moderna）疫苗后新发抗中性粒细胞胞浆抗体相关性血管炎
Cureus. 2021 Nov 16;13(11):e19616. doi: 10.7759/cureus.19616. eCollection 2021 Nov.
2
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.病例报告：辉瑞-生物科技 COVID-19 mRNA 疫苗接种后出现横纹肌溶解症和寡免疫细胞性新月体性肾小球肾炎的抗中性粒细胞胞质抗体相关性血管炎。
Front Immunol. 2021 Sep 30;12:762006. doi: 10.3389/fimmu.2021.762006. eCollection 2021.
3
新型冠状病毒肺炎疫苗相关血管炎：一项系统评价
SAGE Open Med. 2024 Aug 30;12:20503121241261165. doi: 10.1177/20503121241261165. eCollection 2024.
4
ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination-A Systematic Review.接种新型冠状病毒2疫苗后抗中性粒细胞胞浆抗体阳性的小血管血管炎——一项系统评价
Vaccines (Basel). 2024 Jun 13;12(6):656. doi: 10.3390/vaccines12060656.
5
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision.患者患有显微镜下多血管炎和非典型溶血尿毒综合征，在接种第三剂抗 SARS-CoV2 疫苗 mRNA-1273 后 3 周进入终末期肾病：病例报告并文献复习。
Medicine (Baltimore). 2023 Dec 15;102(50):e36560. doi: 10.1097/MD.0000000000036560.
6
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.截至2023年5月SARS-CoV-2疫苗接种后新发的风湿性免疫介导炎症性疾病：一项系统评价
Vaccines (Basel). 2023 Oct 8;11(10):1571. doi: 10.3390/vaccines11101571.
7
New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome.新型冠状病毒感染及疫苗接种后新发系统性血管炎：触发因素、表型及结局。
Clin Rheumatol. 2023 Oct;42(10):2761-2775. doi: 10.1007/s10067-023-06694-6. Epub 2023 Jul 8.
8
Renal Complications Following COVID-19 Vaccination: A Narrative Literature Review.新冠疫苗接种后的肾脏并发症：一篇叙述性文献综述
Indian J Community Med. 2023 Mar-Apr;48(2):214-219. doi: 10.4103/ijcm.ijcm_654_22. Epub 2023 Apr 7.
9
New insights of antineutrophil cytoplasmic antibody-associated vasculitis from the perspective of COVID-19 vaccination.从 COVID-19 疫苗接种的角度看抗中性粒细胞胞质抗体相关性血管炎的新认识。
Clin Exp Immunol. 2023 Oct 13;213(3):301-309. doi: 10.1093/cei/uxad043.
10
Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Renal Vasculitis Following COVID-19 Vaccination: A Case Report and Literature Review.新型冠状病毒肺炎疫苗接种后抗中性粒细胞胞浆抗体（ANCA）相关性肾血管炎：一例报告及文献综述
Cureus. 2022 Oct 11;14(10):e30206. doi: 10.7759/cureus.30206. eCollection 2022 Oct.
Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine.
辉瑞-BioNTech新冠疫苗接种后抗中性粒细胞胞浆自身抗体相关肾小球肾炎
Kidney Int Rep. 2021 Dec;6(12):3087-3089. doi: 10.1016/j.ekir.2021.08.012. Epub 2021 Aug 17.
4
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine.辉瑞-BioNTech COVID-19 疫苗接种后与抗中性粒细胞胞浆抗体相关的血管炎。
Am J Kidney Dis. 2021 Oct;78(4):611-613. doi: 10.1053/j.ajkd.2021.06.016. Epub 2021 Jul 17.
5
De novo vasculitis after mRNA-1273 (Moderna) vaccination.mRNA-1273（Moderna）疫苗接种后新发血管炎。
Kidney Int. 2021 Aug;100(2):474-476. doi: 10.1016/j.kint.2021.05.016. Epub 2021 Jun 1.
6
ANCA glomerulonephritis after the Moderna COVID-19 vaccination.莫德纳新冠疫苗接种后发生的抗中性粒细胞胞浆抗体相关性肾小球肾炎
Kidney Int. 2021 Aug;100(2):473-474. doi: 10.1016/j.kint.2021.05.017. Epub 2021 May 31.
7
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.抗中性粒细胞胞浆抗体相关性血管炎更新：遗传发病机制。
Front Immunol. 2021 Mar 26;12:624848. doi: 10.3389/fimmu.2021.624848. eCollection 2021.
8
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.BNT162b2 mRNA新冠疫苗的安全性与有效性。回复
N Engl J Med. 2021 Apr 22;384(16):1578. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.
9
ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎。
Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y.
10
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19.新冠肺炎重症患者中与系统性自身免疫性风湿疾病相关的自身抗体
Ann Rheum Dis. 2020 Dec;79(12):1661-1663. doi: 10.1136/annrheumdis-2020-218009. Epub 2020 Jun 24.